Health Canada
Symbol of the Government of Canada
Consumer Product Safety

Incident Report

Subform I: General Information

1. Report Type.

New incident report

Incident Report Number: 2007-8344

2. Registrant Information.

Registrant Reference Number: ORTHO HOME DEFENSE MAX INSECTICIDE POUR LE PERIMET

Registrant Name (Full Legal Name no abbreviations): Scotts Canada Ltd.

Address: 2000 Argentia Road, Plaza 5, Suite 101

City: Mississauga

Prov / State: Ontario

Country: Canada

Postal Code: L5N2R7

3. Select the appropriate subform(s) for the incident.

Human

4. Date registrant was first informed of the incident.

29-JUL-07

5. Location of incident.

Country: CANADA

Prov / State: BRITISH COLUMBIA

6. Date incident was first observed.

29-JUL-07

Product Description

7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.

Active(s)

PMRA Registration No. 27520      PMRA Submission No.       EPA Registration No.

Product Name: Green Cross Creepy Crawly Indoor Outdoor Insect Control Ready To Use

  • Active Ingredient(s)
    • PERMETHRIN

7. b) Type of formulation.

Application Information

8. Product was applied?

Yes

9. Application Rate.

Unknown

10. Site pesticide was applied to (select all that apply).

Site: Res. - Out Home / Rés - à l'ext.maison

11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).

To be determined by Registrant

12. In your opinion, was the product used according to the label instructions?

Unknown

Subform II: Human Incident Report (A separate form for each person affected)

1. Source of Report.

Other

2. Demographic information of data subject

Sex: Male

Age: >19 <=64 yrs / >19 <=64 ans

3. List all symptoms, using the selections below.

System

  • General
    • Symptom - Sweating
    • Symptom - Chills
  • Gastrointestinal System
    • Symptom - Vomiting
  • Nervous and Muscular Systems
    • Symptom - Dizziness
    • Symptom - Dizziness
    • Specify - Feeling Faint

4. How long did the symptoms last?

Unknown / Inconnu

5. Was medical treatment provided? Provide details in question 13.

Unknown

6. a) Was the person hospitalized?

Unknown

6. b) For how long?

7. Exposure scenario

Non-occupational

8. How did exposure occur? (Select all that apply)

Application

9. If the exposure occured during application or re-entry, what protective clothing was worn? (select all that apply)

Unknown

10. Route(s) of exposure.

Unknown

11. What was the length of exposure?

Unknown / Inconnu

12. Time between exposure and onset of symptoms.

>2 hrs <=8 hrs / > 2 h < = 8 h

13. Provide any additional details about the incident (eg. description of the frequency and severity of the symptoms, type of medical treatment, results from medical tests, outcome of the incident, amount of pesticide exposed to, etc.)

History: Caller's [age] year old son applied product outdoors 2 hrs ago. No known direct exposure reported during product application. Patient suddenly developed dizziness, chills and then sweating, feeling of fainting, and vomiting after he ate his dinner a short while ago. Caller is concerned the product may have poisoned her son. Assessment: Given the history and no known exposure, these symptoms would not be anticipated from the AI's involved and therefore symptoms are not related to product use. This product has a wide margin of safety and low level of toxicity to it when used according to the labeled directions. Adverse effects are not expected following normal, routine use. Absorption or systemic toxicity not expected. Because symptoms are present, would consider other medical concerns and recommend that your son seek further exam and treatment by an MD to rule out other possible causes. Please CB PRN or have the patient's physician CB PRN if further toxicity info is needed. Note: PMRA: Based on the toxicologic profile of the product and the alleged contact/effect in the incident description, the symptoms alleged would be inconsistent with what would be expected from the described product contact.

To be determined by Registrant

14. Severity classification.

Minor

15. Provide supplemental information here.